688192 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Dizal (Jiangsu) Pharmaceutical Co., Ltd. engages in the discovery, development, and commercialization of innovative medicines. It researches, develops translational science, new-drug molecular design, and screening technology for the treatment of cancer, immunological diseases, and chronic kidney diseases. The company was founded by Xiao Lin Zhang on October 27, 2017 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
688192 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company